Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 164 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1631 5.8 months Newly diagnosed GBM 4 Chemotherapy
Groupe Hospitalier Pitie´Salpetriere France 8/2011
Treatment Details: Patients: This study involved 70 patients with newly diagnosed glioblastoma multiforme. The median age was 77 years and 40% were male. Treatment: Patients were treated with the chemoth
 
1632 5.8 months Malignant pleural mesothelioma 4 Biologic therapy
Dana-Farber Cancer Institute United States 6/2008
Treatment Details: Patients: This phase 2 study involved 24 patients with malignant plural mesothelioma. There were 15 men and 9 women, ranging in age from 38 to 76 years of age. The median age was 62.5 yea
 
1633 5.8 months Newly diagnosed GBM 4 Chemotherapy
Institut Gustave Roussy France 4/2003
Treatment Details: Patients: This multicentre Phase II study involved 52 patients with glioblastoma multiforme who had not been administered chemotherapy previously. Patients were divided into two groups – 25
 
1634 5.8 months metastatic melanoma 4 Immunotherapy
Radiation
Aarhus University Hospital Denmark 10/2005
Treatment Details: Patients: This Phase II study involved 45 patients with metastatic melanoma. Treatment: The treatment consisted of low-dose total body irradiation and a kind of immunotherapy (subcutane
 
1635 5.8 months GBM (recurrent) 5 Chemotherapy
Dartmouth-Hitchcock Medical Center United States 2/2005
Treatment Details: Patients: This Phase II trial involved 15 patients with glioblastoma multiforme and 5 patients with anaplastic astrocytoma. Eleven patients were men, and nine were women. The mean age was
 
1636 5.7 months Recurrent GBM 4 Chemotherapy
Mayo Clinic United States 4/2009
Treatment Details: Patients: This phase 2 trial involved 66 patients with recurrent glioblastoma multiforme (GBM). Of these, 29 were female, and 37 were male. Age range of patients was 26-78 years old, with
 
1637 5.7 months Malignant Pleural Mesothelioma 5 Chemotherapy
Mayo Clinic and Mayo Foundation United States 4/2008
Treatment Details: Patients: In this study, malignant pleural mesothelioma patients were separated into 2 treatment groups. Group 1 consisted of 23 patients with a median age of 71 years; 96% were male. The
 
1638 5.7 months Recurrent or progressive GBM 4 Biologic therapy
Cleveland Clinic United States 4/2013
Treatment Details: Patients: This phase 2 study involved 56 recurrent or progressive glioblastoma patients. The median patient age was 56 years and 63% were male. Treatment: Patients were treated with th
 
1639 5.6 months Advanced NSCLC 3 Chemotherapy
University of Ulsan College of Medicine Korea 12/2011
Treatment Details: Patients: This phase II study involved 14 patients with advanced or metastatic non-small-cell lung cancer who had received previous treatments. The median patient age was 59 years and 57.1
 
1640 5.6 months Recurrent GBM 4 Biologic therapy
Mayo Clinic United States 9/2013
Treatment Details: Patients: This phase 2 study involved 54 recurrent glioblastoma patients. The median patient age was 55 years; no gender information was provided. Treatment: Patients received biologic
 
Page 164 of 187  | Previous Page  | Next Page